| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 24 |
| 1 | ASPIRIN | 22 |
| 2 | ASPIRIN 325 MG | 22 |
| 3 | ASPIRIN 81 MG | 22 |
| 4 | ONABOTULINUMTOXINA | 22 |
| 5 | ROSUVASTATIN | 18 |
| 6 | SIMVASTATIN | 18 |
| 7 | OLANZAPINE | 17 |
| 8 | ARIPIPRAZOLE | 16 |
| 9 | LEVOTHYROXINE SODIUM | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AESCULUS HIPPOCASTANUM WHOLE | 2 | 0.0267 |
| 1 | AGRIMONIA EUPATORIA | 2 | 0.0263 |
| 2 | CENTAURIUM ERYTHRAEA | 2 | 0.0260 |
| 3 | APRACLONIDINE | 1 | 0.0090 |
| 4 | NELFINAVIR MESYLATE | 13 | 0.0062 |
| 5 | ETRAVIRINE | 15 | 0.0034 |
| 6 | SORBITOL | 2 | 0.0033 |
| 7 | DARUNAVIR 600 MG | 15 | 0.0024 |
| 8 | RALTEGRAVIR | 12 | 0.0023 |
| 9 | BARIUM SULFATE | 1 | 0.0023 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 1 | Plasma Volume Expander [EPC] | 2 | 0.0006 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 15 | 0.0006 |
| 3 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 4 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 5 | Protease Inhibitor [EPC] | 15 | 0.0003 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 15 | 0.0003 |
| 7 | Acetylcholine Release Inhibitor [EPC] | 30 | 0.0003 |
| 8 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 16 | 0.0003 |